Liquid Tumor Biopsy
Market
Liquid Tumor Biopsy Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Liquid Tumor Biopsy Market Size and Growth
The liquid tumor biopsy market is rapidly expanding, driven by advancements in non-invasive cancer diagnostics. The global market size is projected to reach approximately $6 billion by 2028, reflecting increasing demand for early detection and personalized treatment. Key factors include technological innovations and expanding applications in oncology research and clinical practice.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Bio-Rad Laboratories
◍ F. Hoffmann-La Roche
◍ Illumina
◍ QIAGEN N.V.
◍ Thermo Fisher Scientific
◍ Amoy Diagnostics
◍ HaploX
◍ Whole Genome Sequencing
◍ Burning Rock Biotech
The Liquid Tumor Biopsy market features major players like Abbott Laboratories, Illumina, and Thermo Fisher Scientific, focusing on non-invasive cancer diagnostics through circulating tumor DNA testing. Their innovative technologies enhance early cancer detection and treatment monitoring, driving market growth. Sales revenue figures include:
- Abbott Laboratories: $43 billion (2022)
- Illumina: $4.5 billion (2022)
- Thermo Fisher Scientific: $39 billion (2022)
Request Sample Report
Market Segmentation
By Application
Clinical Laboratories
Hospital
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
